Structural Basis for Diltiazem Block of a Voltage-Gated Ca2+ Channel.
Ontology highlight
ABSTRACT: Diltiazem is a widely prescribed Ca2+ antagonist drug for cardiac arrhythmia, hypertension, and angina pectoris. Using the ancestral CaV channel construct CaVAb as a molecular model for X-ray crystallographic analysis, we show here that diltiazem targets the central cavity of the voltage-gated Ca2+ channel underneath its selectivity filter and physically blocks ion conduction. The diltiazem-binding site overlaps with the receptor site for phenylalkylamine Ca2+ antagonist drugs such as verapamil. The dihydropyridine Ca2+ channel blocker amlodipine binds at a distinct site and allosterically modulates the binding sites for diltiazem and Ca2+ Our studies resolve two distinct binding poses for diltiazem in the absence
SUBMITTER: Tang L
PROVIDER: S-EPMC6738535 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA